Main Article Content

Authors

Piedad Restrepo de Rojas, Universidad del Valle

Centro de Invetigaciones. Facultad de Química Farmaceutica. Universidad de Antioquia. Medellín, Colombia.

Greenberger PA. Prospetive evaluation of elevated serum theophylline concentrations to determine if high concentrations are predictable. Am J Med 1991; 95: 67-9. DOI: https://doi.org/10.1016/0002-9343(91)90075-9

Kuma N, Ashutosh N. Use of serum theophylline level as a guide to optimun therapy in patients with chronic obstructive lung disease. J Clin Pharmacol 1990; 30: 324-29. DOI: https://doi.org/10.1002/j.1552-4604.1990.tb03601.x

Gibaldi M. Biopharmaceutis and clinical pharmacokinetics. 3rd ed. Philadelphia; Lea & Febiger. 1984. Pp. 77-8.

American Medical Association. Drugs evaluations. 6th ed. Philadelphia; WB Saunders. 1986. Pp. 406-11.

Monzón D. Introducción al diseño de experimentos. 2ª ed. Maracay; Universidad Central de Venezuela. 1986. Pp. 50-8.

Bowman WC, Rand MJ. Texbook of pharmacology. 2nd ed. London; Blackwell Scientific Publications. 1980. Pp. 40-5.

Avendaño C. Introducción a la química farmacéutica. New York; Interamericana McGraw-Hill. 1993. Pp. 278-88.

Dunagan W, Claiborne R. Manual de terapéutica médica. 7ª ed. Departament of Medicine, Washington University. 1991. Pp. 249-50.

Trnavska Z. Theophylline protein binding. Arzeimttelforschung 1990; 40: 166-67.

Capps N. General practice theophylline audit in the Exeter Health District. J Clin Pharm Ther 1990; 15: 101-07. DOI: https://doi.org/10.1111/j.1365-2710.1990.tb00363.x

Soto J, Sacristán JA. Concentraciones plasmáticas de teofilina en los pacientes con enfermedad pulmonar obstructiva crónica. Med Clin 1992; 98: 60-5.

Chandler MHH. Home monitoring of theophylline levels: a novel therapeutic approah. Pharmacotheraphy 1990; 10: 294-300. DOI: https://doi.org/10.1002/j.1875-9114.1990.tb02586.x

Gibaldi M, Perrier D. Pharmacokinetics. Vol 1. Marcel Dekker, New York, 1975. DOI: https://doi.org/10.1007/978-3-642-46314-3_1

Restrepo de Rojas, P. (1995). EStudio de Biodisponibilidad de dos preparados comerciales de teofilina. Colombia Medica, 26(2), 42–46. https://doi.org/10.25100/cm.v26i.2.1740

Downloads

Download data is not yet available.